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Heritability and genetic correlations of obesity indices
with ambulatory and office beat-to-beat blood pressure
in the Oman Family Study
Tengfei Mana, Ilja M. Noltea, Deepali Jajub, Zahir A.M. Al-Anqoudic, M. Loretto Muñoza,
Mohammed O. Hassand, Said Al-Yahyaeee, Riad A. Bayoumif, Anthony G. Comuzzieg,
John S. Florash, Arie M. van Rooni, Harriëtte Riesej, Sulayma Albarwanib, and Harold Sniedera
Objective: To more precisely and comprehensively
estimate the genetic and environmental correlations
between various indices of obesity and BP.
Methods: We estimated heritability and genetic
correlations of obesity indices with BP in the Oman
family study (n¼1231). Ambulatory and office beat-
to-beat BP was measured and mean values for SBP and
DBP during daytime, sleep, 24-h and 10 min at rest
were calculated. Different indices were used to
quantify obesity and fat distribution: BMI, percentage
of body fat (%BF), waist circumference and waist-to-
height ratio (WHtR). SOLAR software was used to
perform univariate and bivariate quantitative genetic
analyses adjusting for age, age2, sex, age-sex and
age2–sex interactions.
Results: Heritabilities of BP ranged from 30.2 to 38.2%
for ambulatory daytime, 16.8–21.4% for sleeping time,
32.1–40.4% for 24-h and 22–24.4% for office beat-to-
beat measurements. Heritabilities for obesity indices
were 67.8% for BMI, 52.2% for %BF, 37.3% for waist
circumference and 37.9% for WHtR. All obesity
measures had consistently positive phenotypic
correlations with ambulatory and office beat-to-beat
SBP and DBP (r-range: 0.14–0.32). Genetic correlations
of obesity indices with SBP and DBP were higher
than environmental correlations (rG: 0.16–0.50; rE:
0.01–0.31).
Conclusion: The considerable genetic overlap between
a variety of obesity indices and both ambulatory and
office beat-to-beat BP highlights the relevance of
pleiotropic genes. Future GWAS analyses should
discover the specific genes both influencing obesity
indices and BP to help unravel their shared genetic
background.
Keywords: ambulatory blood pressure, correlations,
heritability, obesity indices, office beat-to-beat blood
pressure
Abbreviations: %BF, percentage of body fat; BP, blood
pressure; GWAS, genome-wide association studies; OFS,




besity plays a major role in adversely affecting
cardiovascular risk factors, including hyperten-
sion, dyslipidemia and diabetes mellitus, which
are probably independent risk factors for atherosclerosis
and cardiovascular events [1]. A recent review emphasized
the intimate pathophysiological relationship between obe-
sity and hypertension [2] and population-based studies
showed that at least two-thirds of hypertension prevalence
can be directly attributed to obesity [3]. The rise in BP with
increases in BMI has been confirmed by various large-scale
cross-sectional as well as longitudinal epidemiological
studies [4–6]. In the longitudinal Coronary Artery Risk
Development in Young Adults study, SBP and DBP did
not change significantly in six examinations during 15 years
among young people with steady BMI values (within 2 kg/
m2 of baseline), whereas in those with a BMI increase over
2 kg/m2, SBP rose annually between 0.31 and 0.83 mmHg
per year and DBP between 0.57 and 0.68 mmHg per year
regardless of their baseline BMI [6]. Cross-sectional surveil-
lance data of both National Health and Nutrition Examina-
tion Surveys (1988–1994 to 1999–2000) [5] in the United
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States and Chinese National Surveys on Students’ Constitu-
tion and Health (2005–2010) [4] examining trends in SBP/
DBP among children and adolescents reported that BP
increased over time but that this increase was reduced
12.0–40.5% after adjustment for BMI, indicating that the
increase in BP was partially because of the rise in BMI.
Meanwhile, a number of twin and family studies also
showed familial aggregation of BMI and BP, which may
be driven by shared genetic and/or environmental factors
[7–9]. These twin and family studies estimated the genetic
and environmental overlap between obesity and BP, but
only used conventional office BP measurements and BMI as
indicator of general obesity. Compared with office BP,
ambulatory BP measurements have a number of advan-
tages, such as providing a larger number of BP measure-
ments, profiling BP behavior and capturing variations over
24-h. Most importantly, it is generally recognized to be
more strongly associated with target organ damage and
also a stronger predictor of cardiovascular morbidity and
mortality [10]. Although BMI is the most commonly
used surrogate marker of obesity, it lacks the capability
of discriminating between body fat and lean mass [11]. A
meta-analysis of 32 different studies on 31 968 individuals
indicated that the BMI definition of obesity failed to identify
nearly 50% of the population with excess percentage of
body fat (%BF) [12]. The latter measure of %BF is recog-
nized as a better predictor of cardiovascular risk factors than
BMI [13]. In addition, more studies showed the importance
of central or abdominal obesity measured by waist circum-
ference and by fat distribution measured by waist-to-height
ratio (WHtR) in predicting cardiovascular risk [14].
To more precisely and comprehensively estimate the
genetic and environmental correlations between obesity
and BP, we analyzed a number of obesity indices in relation
to both ambulatory and office beat-to-beat BP measures
using data from the Oman Family Study (OFS). The OFS is a
population-based family study from an isolated population
that is environmentally and genetically homogeneous and
is expected to have better power to examine the genetic
contributions to BP and obesity indices and their overlap




Five large, extended and highly consanguineous families
totaling 1231 individuals with 304, 142, 225, 279 and 281
volunteers, each living in a separate village within a perime-
ter of 20km around the City of Nizwa. Interviewed people
represented approximately 10–15% of the total number of
individuals in these five pedigrees. They were 16–80 years
old and all voluntarily took part in the study, appeared
healthy, and had no clinical complaints as determined by
a questionnaire. First cousin marriages represent more than
50% of all marriages (more information can be found in
Supplementary Table 1, http://links.lww.com/HJH/B305).
Polygamy is widely practiced with some men marrying up
to fourwives [16]. Becauseof intermarriages between the five
pedigrees, SOLAR considered all volunteers in the cohort as
one family whenever calculating heritability [17]. Relative
pairs of those five families were described in the supplemen-
tal table, http://links.lww.com/HJH/B305. The study was
approved by the Medical Research and Ethics Committee
of Sultan Qaboos University. A written and signed or thumb-
printed rubber-stamped informed consent was obtained
from each participant or a parent and/or legal guardian if
participants were under the age of 18 years.
Ambulatory and office beat-to-beat blood
pressure measurement
Ambulatory BP measurements were recorded for a 24-h
period on the first home visit, using the auscultatory mode
of the validated Schiller BR 102 ambulatory BP monitor
(Schiller AG, Baar, Switzerland) [18]. With the participant
seated, the appropriate size cuff was fixed to the nondomi-
nant arm and three BP readings taken, whereas at the same
time, three additional BP readings were taken with a cali-
bratedmercury sphygmomanometer on thedominant arm to
confirm accuracy of the ambulatory BP measurements.
Recordings were accepted and ambulatory BP recordings
started when the average of both measurement methods did
not differ by more than 5mmHg. To reduce movement
artefacts during ambulatory BP recordings, participants were
discouraged from strenuous physical activity. The BP moni-
tor was programmed to record BP every 30min from 07:30 to
21:30 and every 60min from 21:30 to 09:30, for a total of 26 h.
The first 2 h of monitoring were considered as an adaptation
period and were not included in the calculationof BP means.
Recordings were accepted when the rate of invalid measure-
ments because of, for example, artefacts was less than 25%
and when the recording lasted for at least 20 consecutive
hours. Quality control of data output from the 24-h monitor
for SBPandDBPwasperformedbyone technician, trained at
identifying artefacts and outliers. The daytime and sleep
periods were determined for each participant according to
their actual waking and sleeping time as recorded in their
diaries and confirmed by changes in BP. The average BP
levels during the total 24-h and during daytime and sleep
periods were calculated [19].
For the office beat-to-beat BP measurement, after report-
ing to the field research center at 0700 h and removing the
BP monitor, participants were made to rest in supine
position for 10min on a comfortable bed, in a quiet office
with a temperature between 24 and 26 8C. Measurements
were acquired for the subsequent 10min using the Task
Force Monitor (CNS Systems, Graz, Austria). The beat-to-
beat BP was recorded using the vascular unloading tech-
nique whereby finger cuff readings were recorded, auto-
matically counterchecked and corrected every minute, by
the oscillometric BP measurements recorded from the
contralateral upper arm.
Participants taking antihypertensive medications (n¼ 189)
were not asked to stop medication, but the measured BP
results were corrected (þ15mmHg for SBP and þ10mmHg
for DBP) prior to analysis as recommended by previous
studies [20,21].
Measurement of obesity indices
Height and weight were measured using standard methods.
Waist circumference was measured by a soft tape at the
Man et al.
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largest circumference between the lowest rib and iliac crest.
%BF was assessed using electrical impedance (Tanita,
Tokyo, Japan) [22], which showed good consistency com-
pared with dual-energy X-ray absorptiometry as the recog-
nized gold standard for measuring %BF (difference
controlled within 5%). BMI was calculated as weight/
height2, where the units of weight and height are kilogram
(kg) and meter (m), respectively. WHtR was calculated as
waist circumference/height, where the units of waist cir-
cumference and height are both centimeters (cm).
Statistical analysis
Descriptive statistics were used to present the baseline
characteristics of the study sample and Student’s t-tests
were used to test for sex differences in the means. Prior
to analysis, distributions of all variables were checked. To
obtain better approximations of normal distributions, meas-
urements of BMI and all BP variables were transformed by
natural logarithm. No outliers (more than four standard
deviations from the mean) were observed. SOLAR (v7.2.5)
software [23] was used to perform univariate and bivariate
quantitative genetic analyses. SOLAR uses a variance-com-
ponent method to analyze family-based quantitative data
by decomposing the phenotypic variance into genetic and
environmental components using the observed covariance
in the trait among family members (Equation 1).
s2P ¼ 2Fs2G þ Is2E; (1)
where F is a nn matrix of kinship coefficients, s2P is the
phenotypic variance, s2G is the variance because of the
additive genetic effects, s2E is the variance because of the
environmental effects and I is the identity matrix of order n.
Each genetic and environmental variance component is
accompanied by a structuring matrix that predicts the
covariance among individuals associated to that compo-
nent. The structuring matrix for s2G is twice the kinship
coefficient (2F) and for unmeasured, nongenetic factors
(i.e. s2E), it is the identity matrix I. SOLAR estimates the
narrow sense heritability (h2) by the proportion of the
phenotypic variance that can be attributed to additive
genetic effects, that is, h2¼s2G /s2P. The significance of
h2 was determined by using a likelihood ratio test where the
log-likelihood of the estimated model is compared with that
of the nested model where s2G is fixed to zero using a chi-
square test with 1 degree of freedom [24].
Bivariate quantitative genetic analyses were conducted
to estimate the genetic and environmental correlations of
obesity indices with BP using SOLAR. The model is an
extension of that shown in Equation 1, where the pheno-
typic covariance between two individuals for two traits is





















where rG is the additive genetic correlation and rE the
environmental correlation between obesity indices and BP,
and e2 is the environmental contribution to the overall
phenotypic variance of the particular BP or obesity indices.
With rG, the extent of common genetic effects on the two
traits being analyzed is measured (i.e. pleiotropy). To test
for the significance of shared genetic effects (jrGj> 0), rG
was first estimated and subsequently fixed to zero in a
nested sub-model allowing for a comparison of the two
models using a likelihood ratio test. Similarly, to test for
complete overlap of genetic effects (jrGj ¼ 1), rG was fixed
to one and compared with the more general model in which
it was freely estimated. If rG¼ 0, it means that the two traits
being analyzed are influenced by independent genetic
factors. If jrGj ¼ 1, the genetic factors are completely shared
[24,25].
RESULTS
A total of 1231 participants with a median age of 28 years
(interquartile range: 21–45) were included in the analyses.
Slightly more women participated in the study (54.9%). Men
were taller and heavier, but no significant sex differences
were found for age. In general, men had significantly higher
BP. There were no significant sex differences for BMI and
waist circumference, but men had lower %BF and WHtR
than women (Table 1).
Results of the univariate analyses showed that heritability
estimates (h2) ranged from 30.2 to 38.2% for daytime BP,
16.8–21.4% for sleeping BP 32.1–40.4% for 24-h BP and 22–
24.4% for office beat-to-beat BP. Heritability estimates were
similar for ambulatory daytime and 24-h BP, but higher than
ambulatory sleep and office beat-to-beat BP. Heritability
estimates of BMI, %BF, waist circumference and WHtR were
67.8, 52.2, 37.3 and 37.9%, respectively. Heritability esti-
mates of all the traits were highly significantly different from
0 (Table 2).
The results of the bivariate quantitative genetic analyses
showed consistently significant and positive phenotypic
correlations between different obesity measurements and
ambulatory daytime BP (rP: 0.14–0.20), sleeping BP (rP:
0.20–0.27), 24-h BP (rP: 0.18–0.23) and office beat-to-beat
BP (rP: 0.14–0.32) (Table 3). The genetic correlations
between BP and obesity indices were always larger than
the environmental correlations, no matter whether BP was
assessed during the daytime (rG: 0.23–0.35 vs. rE: 0.01–
0.12), at night (rG: 0.34–0.49 vs. rE: 0.07–0.20), during 24-h
(rG: 0.26–0.39 vs. rE: 0.05–0.16) or as beat-to-beat mea-
surement at the office (rG: 0.16–0.50 vs. rE: 0.12–0.31),
except for BMI and office beat-to-beat DBP (rG: 0.20 vs. rE:
0.22).
The genetic correlations of the different obesity indices
(BMI, %BF, waist circumference and WHtR) with ambula-
tory BP seemed to be higher in sleeping BP (rG: 0.34–0.49)
compared with daytime BP (rG: 0.23–0.35) and 24-h BP (rG:
0.26–0.39). Table 3 shows that all these rGs were signifi-
cantly greater than 0 except for the one between WHtR and
daytime SBP (rG¼ 0.23, P¼ 0.051). However, as expected,
the genetic factors were not completely shared as all rGs
were significantly less than 1. No large differences were
found between the genetic correlations of SBP (rG: 0.23–
0.50) and DBP (rG: 0.16–0.49) with the different
obesity measures.
Genetic associations of obesity indices with BP
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No significant environmental correlations were observed
between the different obesity indices and ambulatory BP,
except for sleep SBP with BMI, waist circumference or
WHtR and 24-h SBP with waist circumference or WHtR.
However, the environmental correlations between office
beat-to-beat BP and obesity indices were all significantly
different from 0 (rE: 0.12–0.31; P< 0.05) and usually larger
than those between ambulatory BP and obesity indices (rE:
0.01–0.20).
DISCUSSION
The aim of our study was to estimate the heritability of
ambulatory and office beat-to-beat BP and various indices
of obesity and to explore to what extent they shared genetic
and/or environmental factors. Our study echoed previous
findings on the heritability estimates and the positive phe-
notypic, genetic and environmental correlations between
office BP and BMI. Here we confirmed substantial genetic
correlations between ambulatory BP and other indices of
general obesity (%BF), abdominal obesity (waist circum-
ference) and fat distribution (WHtR). Shared genetic factors
contributed more to the phenotypic correlations than envi-
ronmental factors. The genetic correlations seemed to vary
under different conditions as they were higher during sleep
than for daytime SBP and DBP.
Our study found moderate heritability for ambulatory
and office beat-to-beat SBP and DBP, which varied for
different measurement conditions. It was higher for day-
time compared with sleep BP and the heritabilities of office
beat-to-beat BP were lower compared with those for ambu-
latory daytime and 24-h BP measurements. These results
were in line with the univariate BP heritability estimates we
published previously [19] and similar to other family studies
of ambulatory BP conducted in different populations (SBP:
ranging from 0.25 to 0.39; DBP: ranging from 0.20 to 0.41)
[26–29]. For example, Fava et al. [26] reported that in 118
Swedish families with 260 siblings (without antihyperten-
sive treatment), heritabilities were significant for ambula-
tory night-time SBP (37%), DBP (32%), ambulatory daytime
SBP (33%), 24-h SBP (30%) and DBP (29%) (P< 0.05 for all).
Another family study conducted in 1009 individuals from
271 nuclear Swiss families also reported significant herita-
bility for ambulatory daytime SBP (39%), night-time SBP
(25%), 24-h SBP (37%) and ambulatory daytime DBP (28%),
night-time DBP (20%), 24-h DBP (26%), respectively [29]. In
a study of African families consisting of 314 individuals (147
men and 167 women) and with at least two hypertensive
siblings, the heritability estimates for ambulatory SBP and
DBP were 0.37 and 0.24, respectively for daytime and 0.34
and 0.37 for night-time measurements (P< 0.05 for all
estimates) [27]. A study of 520 white European nuclear
families including 2020 individuals reported heritabilities
of 0.33 for mean 24-h SBP and 0.41 for mean 24-h DBP [28].
TABLE 1. Descriptive statistics of the Oman Family Study stratified by sex
Men Women
Characteristics N Statistica N Statistica P value
Anthropometric measurements
Age (years) 554 26.5 (20.0–42.0) 677 30.0 (22.0–45.0) NS
Height (cm) 554 165.7 (7.3) 677 152.2 (5.5) <0.01
Weight (kg) 554 67.0 (58.0–77.0) 677 56.0 (49.5–67.0) <0.01
BP measures
Daytime SBP (mmHg) 534 127.0 (121.0–135.0) 644 119.0 (111.0–128.0) <0.01
Daytime DBP (mmHg) 534 82.0 (76.8–89.0) 644 80.0 (74.0–88.0) <0.01
Sleep SBP (mmHg) 513 109.0 (102.0–118.5) 625 104.0 (95.0–114.5) <0.01
Sleep DBP (mmHg) 513 68.0 (61.0–75.0) 625 66.0 (59.0–73.0) <0.05
Total 24-h SBP (mmHg) 523 124.0 (117.0–131.0) 632 116.0 (108.0–125.0) <0.01
Total 24-h DBP (mmHg) 523 79.0 (74.0–86.0) 632 77.0 (71.3–84.0) <0.01
Office beat-to-beat SBP (mmHg) 507 116.4 (108.2–124.9) 616 105.1 (98.2–113.0) <0.01
Office beat-to-beat DBP (mmHg) 507 74.0 (68.0–82.1) 616 66.6 (60.4–73.0) <0.01
Obesity index
BMI (kg/m2) 554 24.6 (20.9–28.2) 677 24.7 (21.2–28.6) NS
Body fat (%) 537 17.9 (8.4) 657 28.2 (9.8) <0.01
Waist circumference (cm) 537 81.0 (14.3) 657 81.2 (14.5) NS
Waist-to-height ratio 537 0.49 (0.09) 657 0.53 (0.10) <0.01
The daytime and sleep periods were determined for each participant according to their actual waking and sleeping time as recorded in their diaries. One hundred and eighty-nine
participants took antihypertensive medications and measured BP results were corrected (þ15 mmHg for SBP and þ10 mmHg for DBP) prior to analysis as recommended by previous
studies. NS, non-significant.
aData expressed as mean (SD) for normally distributed variable or median (interquartile range) in case of skewed distribution.
TABLE 2. Heritability estimates of blood pressure and obesity
measurements
Traits N h2 SE P-value
BP measures
Daytime SBP 1178 0.302 0.048 4.271023
Daytime DBP 1178 0.382 0.052 2.151030
Sleep SBP 1138 0.214 0.049 4.321010
Sleep DBP 1138 0.168 0.047 8.0106
Total 24-h SBP 1155 0.321 0.051 8.271023
Total 24-h DBP 1155 0.404 0.054 3.591030
Office beat-to-beat SBP 1123 0.244 0.053 5.11010
Office beat-to-beat DBP 1123 0.220 0.052 1.19108
Obesity index
BMI 1231 0.678 0.050 7.701057
Body fat 1214 0.522 0.056 2.351035
Waist circumference 1204 0.373 0.053 7.301021
Waist-to-height ratio 1204 0.379 0.053 3.231022
Models were adjusted for age, sex, age2, age sex and age2 sex. BP, blood pressure.
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Some of this variation in BP heritability estimates may be
because of different genes contributing to BP regulation
under different measurement conditions, such as daytime
vs. night-time or office vs. real life, which was also shown in
previous twin studies [30,31]. For daytime vs. night-time we
confirmed this in our own data by performing bivariate
analyses of ambulatory BP during daytime and sleep. The
genetic correlation between daytime and sleep was 0.83 for
SBP and 0.69 for DBP. Both correlations were significantly
different from 1 (P< 0.001) indicating partly different genes
influencing BP during these measurement conditions.
These result are further supported by findings from mouse
model studies showing rhythmic gene expression in normal
heart and aorta under light–dark conditions with two major
peaks: one in the light and one in the dark [32,33].
Earlier heritability estimates of obesity indices varied
among different populations (BMI: ranging from 0.16 to
0.85; %BF: ranging from 0.35 to 0.43; waist circumference:
ranging from 0.37 to 0.81) [34–36]. Taking abdominal
obesity as an example, Davey et al. [37] reported that the
heritability was over 90% for abdominal obesity in an Indian
population, whereas a family study in an Old Order Amish
community showed a heritability of 37% for waist circum-
ference and 13% for waist-to-hip ratio, respectively [38].
Compared with above studies, our study reported moderate
(37.3–67.8%) heritability estimates for the obesity indices.
Our study found consistently significant and positive
phenotypic correlations between BP and obesity indices.
This pattern was consistent with results from large-scale
epidemiological studies [39]. Virginija et al. [39] reported
that significant associations (adjusted odds ratio ranged
from 2.6 to 7.4) were found between overweight, obesity,
or high waist circumference with high BP after adjusting for
age and sex among Lithuanian adolescents. Some animal
studies have suggested that the association between obesity
and BP was mediated by leptin [40], but human studies do
not support this [41]. In our own data, %BF showed the
largest correlation with leptin (r¼ 0.764; P< 0.01), fol-
lowed by the other three obesity indices (r ranging from
0.472 to 0.621; all P values <0.01). Compared with the four
obesity indices, we found much lower correlations (r
ranging from 0.035 to 0.144) of leptin with the different
BP measurements in our study. The pattern of correlations
between leptin and BP measures closely mimicked the
results for %BF, but were much more modest and often
nonsignificant (Supplementary Table 2, http://link-
s.lww.com/HJH/B305). Obesity is the well-recognized risk
factor for hypertension and genetic factors may play an
important role in this association. Howe et al. [42] reported
that a genetic risk score composed of 32 BMI loci identified
in genome-wide association studies (GWAS) was strongly
associated with SBP both at age 6 and 17 years and in a
meta-analysis [43] on 57 464 hypertensive cases and 41 256
controls, it was found that the first GWAS-identified obesity
gene (FTO, also known as FTO alpha-ketoglutarate-depen-
dent dioxygenase and located on chromosome 16. It was
the first gene identified in a genome-wide association study
of BMI as an index of general obesity [44]) was significantly
associated with hypertension.
Our study also identified significant genetic contribu-
tions to the phenotypic correlation of different obesity
indices with ambulatory and office beat-to-beat BP. This
pattern was generally in line with twin and family studies of
conventionally measured BP and BMI [7–9]. For example,
TABLE 3. Bivariate quantitative genetic analysis results of obesity indices with ambulatory daytime, sleep, 24-h and office beat-to-beat
























Ambulatory daytime SBP Ambulatory daytime DBP
BMI 1231 0.31a (0.09) 0.04 (0.07) 0.17c 0.88/0.12 0.34a (0.08) 0.05 (0.08) 0.20c 0.89/0.11
Body fat 1222 0.31a (0.11) 0.01 (0.06) 0.14c 0.96/0.04 0.35a (0.09) 0.06 (0.06) 0.19c 0.84/0.16
Waist circumference 1223 0.25a (0.11) 0.11 (0.05) 0.16c 0.55/0.45 0.34a (0.10) 0.08 (0.06) 0.18c 0.74/0.26
Waist-to-height ratio 1223 0.23 (0.11) 0.12 (0.05) 0.16c 0.51/0.49 0.32a (0.10) 0.09 (0.06) 0.18c 0.70/0.30
Ambulatory sleep SBP Ambulatory sleep DBP
BMI 1231 0.43a (0.10) 0.18b (0.07) 0.27c 0.64/0.36 0.49a (0.10) 0.07 (0.07) 0.22c 0.82/0.18
Body fat 1222 0.43a (0.12) 0.12 (0.06) 0.23c 0.69/0.31 0.49a (0.11) 0.07 (0.05) 0.21c 0.80/0.20
Waist circumference 1219 0.36a (0.12) 0.19b (0.05) 0.24c 0.47/0.53 0.44a (0.12) 0.11 (0.05) 0.20c 0.63/0.37
Waist-to-height ratio 1219 0.34a (0.12) 0.20b (0.05) 0.24c 0.44/0.56 0.42a (0.12) 0.10 (0.05) 0.20c 0.64/0.36
Ambulatory 24-h SBP Ambulatory 24-h DBP
BMI 1231 0.33a (0.09) 0.10 (0.07) 0.21c 0.77/0.23 0.38a (0.08) 0.05 (0.08) 0.23c 0.90/0.10
Body fat 1222 0.35a (0.10) 0.06 (0.06) 0.18c 0.82/0.18 0.38a (0.09) 0.08 (0.07) 0.23c 0.82/0.18
Waist circumference 1220 0.29a (0.11) 0.14b (0.06) 0.20c 0.55/0.45 0.39a (0.10) 0.09 (0.06) 0.22c 0.76/0.24
Waist-to-height ratio 1220 0.26a (0.11) 0.16b (0.06) 0.20c 0.49/0.51 0.36a (0.10) 0.11 (0.06) 0.21c 0.70/0.30
Office beat-to-beat SBP Office beat-to-beat DBP
BMI 1231 0.42a (0.10) 0.31b (0.06) 0.32c 0.53/0.47 0.20a (0.12) 0.22b (0.07) 0.19c 0.39/0.61
Body fat 1224 0.50a (0.12) 0.17b (0.05) 0.27c 0.57/0.43 0.34a (0.14) 0.12b (0.05) 0.18c 0.54/0.46
Waist circumference 1219 0.32a (0.14) 0.24b (0.05) 0.26c 0.34/0.66 0.21a (0.15) 0.15b (0.05) 0.16c 0.33/0.67
Waist-to-height ratio 1219 0.29a (0.14) 0.23b (0.05) 0.24c 0.34/0.66 0.16a (0.15) 0.14b (0.05) 0.14c 0.29/0.71
Models were adjusted for age, sex, age2, age sex and age2 sex. rE, environmental correlation; rG, genetic correlation; rP, phenotypic correlation; SE, standard error.




















aGenetic correlations significantly different from 0 (P<0.05).
bEnvironmental correlations significantly different from 0 (P<0.05).
cPhenotypic correlations significantly different from 0 (P< 0.05).
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Schieken, et al. [7] found a significant phenotypic correla-
tion between SBP and BMI in a twin study of children
(r¼ 0.29) and showed that the percentage of variance of
SBP explained by genetic factors common between SBP
and BMI was 8%. Similar findings were reported in an adult
study of Chinese twins, which showed that the genetic and
unique environmental correlations were 0.38 and 0.17,
respectively, between BMI and SBP and 0.48 and 0.12
between BMI and DBP. The genetic factors influencing
both BMI and BP accounted for 6 and 7% of the total
variance in SBP and DBP, respectively [8]. In a large family
study of 2912 individuals from 767 adult nuclear families,
the phenotypic correlation between SBP and BMI was 0.36
and the genetic correlation was 0.30 [9]. Our study did not
find significant environmental correlations between ambu-
latory BP and obesity indices, except for sleep SBP with
BMI, waist circumference and WHtR and for 24-h BP with
waist circumference and WHtR. Thus, shared genetic fac-
tors had a larger contribution to the phenotypic correlations
between ambulatory BP and obesity than environmental
factors. However, it was found that all environmental
correlations of obesity indices with office beat-to-beat BP
were significantly different from 0 and were higher than
with ambulatory BP. In addition, in the current study,
genetic correlations with obesity indices seemed to be
lower for daytime BP than for sleeping BP but no differ-
ences were found between SBP and DBP. This might
possibly be because of partly different genes regulating
daytime and night-time BP [30,45].
A strength of this family study is that it was conducted in
a homogeneous Arab population, in which the individuals
had a very similar genetic background (tradition of encour-
aging consanguineous marriage) and shared environmental
effects (living in a relatively isolated region). Consequently,
it was expected to have somewhat better power to examine
the genetic contributions to BP and obesity indices than
studies conducted in outbred, heterogeneous populations
[15]. Another strength is that BP values were measured
using 24-h ambulatory monitoring, which is believed to
better predict target organ damage than conventional BP
methods [46]; and various indices, including %BF as a more
accurate measure of general obesity than BMI, waist cir-
cumference representing abdominal obesity and WHtR
representing fat distribution, were used to capture different
aspects of obesity. Furthermore, the effects of hypertension
medication were corrected to optimally preserve genetic
variability as recommended by previous studies [20,21] to
ensure data quality. However, there are also some limita-
tions of this study. Firstly, although our study contained
data on more than 1200 participants, the sample size may
still not be large enough to clearly discriminate between
genetic and/or environmental correlations among different
obesity indices and/or BP conditions. Secondly, waist-to-
hip ratio (WHR) would also be a good index to represent
central obesity, but unfortunately hip circumference was
only measured in part of the sample. Instead, we decided to
use WHtR, on which we had complete data and showed a
strong phenotypic correlation (rP¼ 0.62, P< 0.01) with
WHR for the part of the sample of which WHR was
available. Furthermore, previous studies also reported that
WHtR and WHR had comparable correlations with SBP (r:
0.41 vs. 0.36) or DBP (r: 0.35 vs. 0.31) [47].
In conclusion, our study quantified the considerable
genetic overlap between a variety of obesity indices and
both ambulatory and office beat-to-beat BP and highlights
the relevance and potential of identification of pleiotropic
genes. More advanced analyses, for example, GWAS could
and should be undertaken to discover the specific genes
both influencing obesity indices and BP, and thus help
unravel the shared genetic background of these two clini-
cally relevant traits.
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